RINVAC ND+IBD

Product Overview

RINVAC ND+IBD is an advanced inactivated oil-emulsion vaccine developed to support stable protection against Newcastle Disease (ND), Variant Infectious Bursal Disease (Variant IBD), and Very Virulent Infectious Bursal Disease (vvIBD) during critical production stages.

The vaccine combines carefully selected strains with high antigenic content to support strong early immune responses and enhanced field protection against circulating disease challenges.

Designed for modern vaccination programs, RINVAC ND+IBD helps poultry producers achieve improved immune stability and flock performance.

Vaccine Strains

Newcastle Disease Virus (NDV)

ND Genotype VII

Developed using:

Reverse-engineering an antigenically matched whole-virus vaccine

This technology aims to achieve improved antigenic matching with circulating field challenges and provide protection that is more closely aligned with real-world disease pressure.

Rather than relying on a conventional strain alone, it utilizes a Whole-Virus ND Vaccine approach designed to support a more accurate and stable immune response.

Infectious Bursal Disease Virus (IBDV)

HQ Strain (Very Virulent IBD)

A very virulent IBD strain selected to support protection against severe field challenges.

FJ Strain (Variant IBD – Genotype A2dB1b)

A variant IBD strain developed to broaden protection against emerging and evolving field variants.

Key Benefits

Whole Virus Technology

Contains two Whole Virus IBD strains:

• Variant IBD
• Very Virulent IBD

Supporting broader field protection against diverse IBD challenges.

High Antigenic Content

Provides high antigenic mass reaching:

10⁹·⁴ EID₅₀

to support strong, early, and sustained immune responses.

Strong Early Immune Response

Supports rapid immune development during critical stages of flock production.

Immunity Gap Support

Helps maintain protection during periods of declining maternal antibodies and increased disease challenge.

Maternal Antibody Support

An important choice for breeder vaccination programs, supporting efficient transfer of maternal antibodies to day-old chicks, particularly against Variant and Very Virulent IBD challenges.